FI119640B - Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia - Google Patents

Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia Download PDF

Info

Publication number
FI119640B
FI119640B FI971274A FI971274A FI119640B FI 119640 B FI119640 B FI 119640B FI 971274 A FI971274 A FI 971274A FI 971274 A FI971274 A FI 971274A FI 119640 B FI119640 B FI 119640B
Authority
FI
Finland
Prior art keywords
alkyl
formula
chloro
dihydro
amino
Prior art date
Application number
FI971274A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI971274A0 (fi
FI971274A (fi
Inventor
Daele Georges Henri Paul Van
Den Keybus Frans Maria Alf Van
Jean-Paul Rene Marie A Bosmans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI971274A0 publication Critical patent/FI971274A0/fi
Publication of FI971274A publication Critical patent/FI971274A/fi
Application granted granted Critical
Publication of FI119640B publication Critical patent/FI119640B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI971274A 1994-09-27 1997-03-26 Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia FI119640B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP94202792 1994-09-27
EP94202792 1994-09-27
US45548695A 1995-05-31 1995-05-31
US45548695 1995-05-31
EP9503691 1995-09-19
PCT/EP1995/003691 WO1996010027A1 (en) 1994-09-27 1995-09-19 N-substituted piperidinyl bicyclic benzoate derivatives

Publications (3)

Publication Number Publication Date
FI971274A0 FI971274A0 (fi) 1997-03-26
FI971274A FI971274A (fi) 1997-03-26
FI119640B true FI119640B (fi) 2009-01-30

Family

ID=26136613

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971274A FI119640B (fi) 1994-09-27 1997-03-26 Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia

Country Status (23)

Country Link
EP (1) EP0784620B1 (de)
JP (1) JP3953097B2 (de)
CN (1) CN1068880C (de)
AT (1) ATE187453T1 (de)
AU (1) AU699152B2 (de)
BR (1) BR9509036A (de)
CA (1) CA2200578C (de)
CZ (1) CZ289031B6 (de)
DE (1) DE69513846T2 (de)
DK (1) DK0784620T3 (de)
ES (1) ES2141383T3 (de)
FI (1) FI119640B (de)
GR (1) GR3032646T3 (de)
HU (1) HU218698B (de)
IL (1) IL115413A (de)
MY (1) MY113202A (de)
NO (1) NO313238B1 (de)
NZ (1) NZ293605A (de)
PL (1) PL182502B1 (de)
PT (1) PT784620E (de)
RU (1) RU2154064C2 (de)
WO (1) WO1996010027A1 (de)
ZA (1) ZA958081B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2332275A1 (en) * 1998-05-14 1999-11-18 Zoltan Tamas Nagy Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
DE60300683T2 (de) 2002-01-16 2006-04-27 Janssen Pharmaceutica N.V. Prucaloprid-n-oxid
US7834010B2 (en) 2003-12-23 2010-11-16 Serodus As Modulators of peripheral 5-HT receptors
BRPI0512535A (pt) 2004-06-24 2008-03-25 Incyte Corp compostos de piperidinas n-substituìdas, suas composições e métodos de modulações
HUE032640T2 (en) 2005-11-08 2017-10-30 Vertex Pharma Heterocyclic modulator of ATP-binding cassette transcripts
US8969386B2 (en) 2007-05-09 2015-03-03 Vertex Pharmaceuticals Incorporated Modulators of CFTR
KR20100101130A (ko) 2007-12-07 2010-09-16 버텍스 파마슈티칼스 인코포레이티드 3-(6-(1-(2,2-디플루오로벤조[ｄ][1,3]디옥솔-5-일)사이클로프로판카복스아미도)-3-메틸피리딘-2-일)벤조산의 고체 형태
CA2707494C (en) 2007-12-07 2018-04-24 Vertex Pharmaceuticals Incorporated Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
NZ602030A (en) 2008-02-28 2014-02-28 Vertex Pharma Heteroaryl derivatives as cftr modulators
LT3150198T (lt) 2010-04-07 2021-12-10 Vertex Pharmaceuticals Incorporated 3-(6-(1-(2,2-difluorbenzo[d][1,3]dioksol-5-il) ciklopropankarboksamido)-3-metilpiridin-2-il)benzoinės rūgšties farmacinė kompozicija ir jos įvedimas
RU2579370C2 (ru) * 2010-04-07 2016-04-10 Вертекс Фармасьютикалз Инкорпорейтед Твердые формы 3-(2, 2-дифторбензо[d][1, 3] диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
PT3068392T (pt) 2013-11-12 2021-05-14 Vertex Pharma Processo de preparação de composições farmacêuticas para o tratamento de doenças mediadas por condutância transmembrana da fibrose quística (cftr)
HUE055423T2 (hu) 2014-11-18 2021-11-29 Vertex Pharma Eljárás nagy áteresztõképességû tesztelõ nagy teljesítményû folyadék-kromatográfia elvégzésére

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
DE3810552A1 (de) * 1988-03-29 1989-10-19 Sandoz Ag Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
NZ243993A (en) * 1991-08-20 1994-10-26 Smithkline Beecham Plc Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
MX9702363A (es) 1997-10-31
CA2200578A1 (en) 1996-04-04
FI971274A0 (fi) 1997-03-26
DK0784620T3 (da) 2000-05-22
FI971274A (fi) 1997-03-26
ES2141383T3 (es) 2000-03-16
NO971376L (no) 1997-05-05
AU699152B2 (en) 1998-11-26
NO971376D0 (no) 1997-03-24
HU218698B (hu) 2000-11-28
EP0784620B1 (de) 1999-12-08
EP0784620A1 (de) 1997-07-23
IL115413A (en) 2000-02-17
NO313238B1 (no) 2002-09-02
DE69513846D1 (de) 2000-01-13
CN1068880C (zh) 2001-07-25
ZA958081B (en) 1997-03-26
PL182502B1 (pl) 2002-01-31
NZ293605A (en) 1998-07-28
WO1996010027A1 (en) 1996-04-04
HUT77173A (hu) 1998-03-02
RU2154064C2 (ru) 2000-08-10
MY113202A (en) 2001-12-31
GR3032646T3 (en) 2000-06-30
DE69513846T2 (de) 2000-07-06
JP3953097B2 (ja) 2007-08-01
IL115413A0 (en) 1995-12-31
BR9509036A (pt) 1997-10-14
ATE187453T1 (de) 1999-12-15
AU3608195A (en) 1996-04-19
CZ289031B6 (cs) 2001-10-17
CN1166171A (zh) 1997-11-26
JPH10506118A (ja) 1998-06-16
PT784620E (pt) 2000-05-31
CZ91897A3 (en) 1997-12-17
CA2200578C (en) 2006-11-07
PL319997A1 (en) 1997-09-01

Similar Documents

Publication Publication Date Title
FI101624B (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(3-hydroksi-4-piperidinyy li)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentso dioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote
FI119640B (fi) Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia
KR100500372B1 (ko) 위장운동 조절성 3- 또는 4-치환된4-(아미노메틸)-피페리딘 유도체의 비사이클릭 벤즈아미드
SK282406B6 (sk) N-(4-Piperidinyl) (dihydrobenzofurán alebo dihydro-2H-benzopyrán) karboxamidové deriváty, spôsob a medziprodukty na ich výrobu a farmaceutické prípravky na ich báze
FI94129B (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(1-alkyyli-3-hydroksi-4-piperidinyyli)bentsamidien valmistamiseksi
US6544997B1 (en) 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
US5053411A (en) N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds
AU718695B2 (en) Esters of 3-hydroxy-piperidinemethanol derivatives
WO2005030722A1 (ja) Ｎ－置換－ｎ－（４－ピペリジニル）アミド誘導体
KR100388253B1 (ko) N-치환된피페리디닐바이사이클릭벤조에이트유도체
USRE34201E (en) N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds
JP3862750B2 (ja) フェニル−オキソ−アルキル−（４−ピペリジニル）ベンゾエート誘導体
HUT77311A (hu) Fenil-oxo-alkil-(4-piperidinil)-benzoát-származékok, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és alkalmazásuk
MXPA97002363A (es) Derivados biciclicos de benzoato de piperidinilon-substituidos
MXPA01006409A (en) 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
MXPA97002356A (en) Derivatives of phenyl-oxy-alkyl- (4-piperidinyl) benzo